Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma

NCT00005580

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +37 more
Locations: New York Presbyterian Hospital - Cornell Campus New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma

NCT00251394

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma

NCT00147953

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University of Cologne Cologne, North Rhine-Westphalia, Germany

View Trial Details

Completed

A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Non-Hodgkin Lymphoma (NHL).

NCT00301288

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Royal Marsden NHS trust Sutton, Surrey, United Kingdom

View Trial Details

Completed

A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)

NCT00301301

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Royal Marsden NHS trust Sutton, Surrey, United Kingdom

View Trial Details

Completed

INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.

NCT00276003

Conditions: Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Lovelace Sandia Health Systems Dept of Hematology Albuquerque, New Mexico, United States

University of New Mexico Albuquerque, New Mexico, United States

View Trial Details

Completed

Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy

NCT01018758

Conditions: Chemotherapy-induced Nausea and Vomiting, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Gruppo Italiano Studio Linfomi Modena, Italy

View Trial Details

Completed

Amifostine for Head and Neck Irradiation in Lymphoma

NCT00136474

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +9 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma

NCT00090038

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: USC KECK School of Medicine Los Angeles, California, United States

Radiant Research Honolulu, Hawaii, United States

Carle Clinic Association Urbana, Illinois, United States

Tufts - New England Medical Center Boston, Massachusetts, United States

View all 45 locations

View Trial Details

Completed

Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas

NCT00374699

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions